Cellular Technology Limited (CTL) is a privately held biotechnology company that built its reputation as a global leader in the enzyme-linked immunospot (ELISPOT) field over the past two decades by establishing the ELISPOT instrumentation and scientific principles that have helped to define the parameters of ELISPOT research for monitoring of cell-mediated immunity.
Headquartered in Shaker Heights, OH, the company focuses on high-throughput ELISPOT assays, multiplex cytokine bead arrays (CBA), flow cytometry (such as phenotyping and multimer readouts), and BrdU proliferation assays.
CTL is uniquely capable of developing, qualifying and validating assays tailored to its clients’ specific needs in its good laboratory practice (GLP) compliant and Clinical Laboratory Improvement Amendments (CLIA) certified laboratory.
Cellular Technology Limited
20521 Chagrin Boulevard